Marc Rendell

10.0k total citations
154 papers, 6.2k citations indexed

About

Marc Rendell is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, Marc Rendell has authored 154 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Endocrinology, Diabetes and Metabolism, 44 papers in Physiology and 43 papers in Surgery. Recurrent topics in Marc Rendell's work include Diabetes Treatment and Management (42 papers), Diabetes Management and Research (40 papers) and Pancreatic function and diabetes (26 papers). Marc Rendell is often cited by papers focused on Diabetes Treatment and Management (42 papers), Diabetes Management and Research (40 papers) and Pancreatic function and diabetes (26 papers). Marc Rendell collaborates with scholars based in United States, Sweden and United Kingdom. Marc Rendell's co-authors include Jacob Rajfer, Pierre Wicker, Martin Rodbell, Annette Mathisen, John Egan, Yoram Salomon, Martin I. Freed, Jo Dole, Daniel Einhorn and Julio Rosenstock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and JAMA.

In The Last Decade

Marc Rendell

152 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Rendell United States 39 3.4k 2.0k 1.4k 1.2k 540 154 6.2k
Antonio E. Pontiroli Italy 42 2.3k 0.7× 960 0.5× 2.3k 1.7× 1.6k 1.3× 396 0.7× 217 5.9k
Sherwyn Schwartz United States 44 5.3k 1.6× 1.9k 0.9× 2.4k 1.8× 1.1k 0.9× 1.2k 2.2× 101 8.1k
Shigehiro Katayama Japan 45 2.5k 0.8× 2.7k 1.4× 1.2k 0.9× 1.1k 0.9× 517 1.0× 224 8.2k
Winfried Siffert Germany 48 1.5k 0.5× 3.7k 1.9× 1.2k 0.9× 1.1k 0.9× 363 0.7× 262 8.4k
Wilhelm Krone Germany 41 1.8k 0.5× 2.7k 1.4× 1.6k 1.2× 2.6k 2.1× 533 1.0× 182 7.8k
Martin Wehling Germany 46 3.1k 0.9× 2.3k 1.2× 1.4k 1.0× 590 0.5× 505 0.9× 249 8.6k
Sandeep Dhindsa United States 34 3.0k 0.9× 1.1k 0.5× 603 0.4× 763 0.6× 1.2k 2.2× 83 5.1k
G. Pozza Italy 41 2.7k 0.8× 1.4k 0.7× 2.8k 2.1× 1.8k 1.4× 455 0.8× 301 7.5k
Morris Schambelan United States 55 3.5k 1.0× 2.9k 1.5× 1.6k 1.2× 1.5k 1.2× 549 1.0× 164 10.6k
Nicholas Emanuele United States 35 5.4k 1.6× 1.6k 0.8× 1.1k 0.8× 803 0.7× 473 0.9× 138 8.3k

Countries citing papers authored by Marc Rendell

Since Specialization
Citations

This map shows the geographic impact of Marc Rendell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Rendell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Rendell more than expected).

Fields of papers citing papers by Marc Rendell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Rendell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Rendell. The network helps show where Marc Rendell may publish in the future.

Co-authorship network of co-authors of Marc Rendell

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Rendell. A scholar is included among the top collaborators of Marc Rendell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Rendell. Marc Rendell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Middlebrooks, Candace D., Qing Li, Carrie Snyder, et al.. (2019). Analysis of the CDKN2A Gene in FAMMM Syndrome Families Reveals Early Age of Onset for Additional Syndromic Cancers. Cancer Research. 79(11). 2992–3000. 9 indexed citations
2.
Hollander, Priscilla, Raymond L. H. Lam, Gregory T. Golm, et al.. (2018). Efficacy and safety of MK‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open‐label clinical trial. Diabetes Obesity and Metabolism. 20(9). 2229–2237. 10 indexed citations
3.
Rendell, Marc. (2016). Albiglutide: a unique GLP-1 receptor agonist. Expert Opinion on Biological Therapy. 16(12). 1557–1569. 16 indexed citations
4.
5.
Tella, Sri Harsha & Marc Rendell. (2014). DPP-4 inhibitors: focus on safety. Expert Opinion on Drug Safety. 14(1). 127–140. 51 indexed citations
6.
Rendell, Marc. (2013). Diabetes: New drug options and old choices. 53(4). 217–227. 3 indexed citations
7.
Rendell, Marc, Halis Kaan Aktürk, & Sri Harsha Tella. (2013). Glargine safety, diabetes and cancer. Expert Opinion on Drug Safety. 12(2). 247–263. 15 indexed citations
8.
Rendell, Marc, et al.. (2013). The future of inpatient diabetes management: glucose as the sixth vital sign. Expert Review of Endocrinology & Metabolism. 8(2). 195–205. 3 indexed citations
9.
Bergren, Dale R., et al.. (2012). The effect of vasoactive agents on post-pressure hyperemia. Microvascular Research. 84(3). 345–350. 2 indexed citations
10.
Casey, Murray Joseph, et al.. (2012). Ethical Dilemma of Mandated Contraception in Pharmaceutical Research at Catholic Medical Institutions. The American Journal of Bioethics. 12(7). 34–37. 2 indexed citations
11.
12.
Drincic, Andjela, et al.. (2009). Alogliptin: a new addition to the class of DPP-4 inhibitors. SHILAP Revista de lepidopterología. 7 indexed citations
13.
Rendell, Marc. (2006). Report on the 2nd Annual Metabolic Diseases World Summit. Expert Review of Endocrinology & Metabolism. 1(4). 467–468. 1 indexed citations
14.
Elias, Nizar, et al.. (2004). Post pressure hyperemia in the rat. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 137(3). 533–546. 10 indexed citations
15.
Rendell, Marc, et al.. (2002). Skin Blood Flow Response in the Rat Model of Wound Healing: Expression of Vasoactive Factors. Journal of Surgical Research. 107(1). 18–26. 24 indexed citations
16.
Apfel, Stuart C., Bruce T. Adornato, Roy Freeman, et al.. (2000). Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy. JAMA. 284(17). 2215–2215. 274 indexed citations
17.
Einhorn, Daniel, et al.. (2000). Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study. Clinical Therapeutics. 22(12). 1395–1409. 301 indexed citations
18.
Rendell, Marc, Jacob Rajfer, P Wicker, & Mark D. Smith. (1999). Sildenafil improved erections and increased successful sexual intercourse in diabetic men with erectile dysfunction. Evidence-Based Medicine. 4(4). 1 indexed citations
19.
Rendell, Marc, et al.. (1998). The Microvascular Composition of the Healing Wound Compared at Skin Sites with Nutritive versus Arteriovenous Perfusion. Journal of Surgical Research. 80(2). 373–379. 12 indexed citations
20.
Rendell, Marc, et al.. (1998). Ischemic and pressure-induced hyperemia: A comparison. Archives of Physical Medicine and Rehabilitation. 79(11). 1451–1455. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio E. Pontiroli Breakdown of academic impact, for papers by Sherwyn Schwartz Breakdown of academic impact, for papers by Shigehiro Katayama Breakdown of academic impact, for papers by Winfried Siffert Breakdown of academic impact, for papers by Wilhelm Krone Breakdown of academic impact, for papers by Martin Wehling Breakdown of academic impact, for papers by Sandeep Dhindsa Breakdown of academic impact, for papers by G. Pozza Breakdown of academic impact, for papers by Morris Schambelan Breakdown of academic impact, for papers by Nicholas Emanuele
Rankless by CCL
2026